FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

HTO Nevada Maximum Zone2 Topical Analgesic Recall

Maximum Zone2 Topical Analgesic, 1oz bottle, for use during a pain sensitive procedure,…

HTO Nevada, Inc. · Lake Oswego, OR

Risk level
Class II
Reported by FDA
Feb 22, 2023
Recall ID
D-0271-2023
Check your lot numberHow we source this data

Summary

HTO Nevada recalled Maximum Zone2 Topical Analgesic starting Feb 9, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0271-2023 on Feb 22, 2023. Reason: cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API. Status: Terminated.

Why it was recalled

cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.

Product description

Maximum Zone2 Topical Analgesic, 1oz bottle, for use during a pain sensitive procedure, distributed by: DERMAL SOURCE, Portland, OR, www.dermalsource.com, 1-866-568-3223, NDC code: 80069-012-01, Drug Facts- For use by licensed professionals only' Active Ingredients- Lidocaine HCL (5%), Epinephrine (0.01%).

Lot numbers, UPCs & expiration codes

Lot #: 795CP-0003, Exp 07/2024.

Where it was sold

Nationwide in the USA and Canada.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0271-2023
Classification
Class II
Status
Terminated
Recall initiated
Feb 9, 2023
FDA report date
Feb 22, 2023
Quantity
1,571 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
HTO Nevada, Inc.

Original FDA data

Every field from FDA enforcement report D-0271-2023, exactly as published.

Show all FDA fields
City
Lake Oswego
State
OR
Status
Terminated
Country
United States
Event ID
91694
Address
6400 Rosewood St
Code information
Lot #: 795CP-0003, Exp 07/2024.
Postal code
97035-5392
Report date
Feb 22, 2023
Product type
Drugs
Recall number
D-0271-2023
Classification
Class II
Recalling firm
HTO Nevada, Inc.
Product quantity
1,571 bottles
Termination date
Nov 17, 2023
Reason for recall
cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Maximum Zone2 Topical Analgesic, 1oz bottle, for use during a pain sensitive procedure, distributed by: DERMAL SOURCE, Portland, OR, www.dermalsource.com, 1-866-568-3223, NDC code: 80069-012-01, Drug Facts- For use by licensed professionals only' Active Ingredients- Lidocaine HCL (5%), Epinephrine (0.01%).
Distribution pattern
Nationwide in the USA and Canada.
Recall initiation date
Feb 9, 2023
Initial firm notification
Letter
Center classification date
Feb 15, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0271-2023, published Feb 22, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls